IL17A and Miyoshi myopathy: Moreover, IL17 production, due to an increased Th17 cell number, induces osteoblast cell death through pyroptosis with the release of IL1β [120] and cooperates with RANKL to further activate osteoclasts enhancing tumor growth and promoting MBD in MM [119].